In a recent Washington Post article by Robert McCartney (http://dtg.fm/43iJ), the importance of careful shopping when it comes to real estate transactions was made clear. The article points to lawsuits currently being brought against individuals accused of arranging kickbacks for steering business to specific companies, arrangements that homebuyers can end up paying for in the form of higher title, mortgage, or other fees.

Today, VentriPoint Diagnostics reported receiving an expanded license from Health Canada that allows the company to sell the VMS™ heart analysis system for clinical use in Canada. The expansion was for the NRV™ application for the analysis of 2-D ultrasound images for patients with non-specific heart disease. The NRV™ application will enable healthcare providers to rapidly and accurately assess the status of the right ventricle in all patients that do not have significant congenital heart defects or pulmonary hypertension, yet may have a variety of other conditions.

Cardium Therapeutics is a San Diego based health sciences and regenerative medicine company that has carefully diversified itself with a strategy designed to provide short-term, mid-term, and long-term growth and revenue. In so doing, they have successfully positioned themselves in several markets, much like a rocket with multiple stages timed for continuous acceleration.

The U.S. entertainment industry is aggressive in nature, comprised of market players producing a vast and diverse offering of experiences and simulations that cater to every imaginable consumer demographic. The gaming segment of the industry has achieved exceptional performance throughout its history, and isn’t showing any signs that it will slow its pace.